African-American Heart Failure Trial

Phase 4

Completed

• Conditions: Congestive Heart Failure

• Registration Number: NCT00047775
• Lead Sponsor: Nitromed

Brief Summary

A placebo-controlled trial of BiDil added to standard therapy in African-American patients with heart failure.

Detailed Description

The overall objective is confirmation of BiDil's Safety and Efficacy in African-American (AFA) Patients with Moderate to Severe Symptomatic Heart Failure.

Study Timeline

• Study Start: 2001-05
• Study First Submitted: 2002-10-18
• Study First Submitted QC: 2002-10-18
• Study First Posted: 2002-10-21
• Study Completion: 2004-08
• Status Verified: 2004-10
• Last Update Submitted: 2005-06-23
• Last Update Posted: 2005-06-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1100

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Trial Locations

Locations (7)

Minneapolis VA Medical Center; 🇺🇸 Minneapolis, Minnesota, United States

Saint Vincents Hospital and Medical Center; 🇺🇸 New York, New York, United States

Boston Medical Center; 🇺🇸 Boston, Massachusetts, United States

Cardiology and Medicine Clinic; 🇺🇸 Little Rock, Arkansas, United States

Miami International Cardiology Consultants; 🇺🇸 Aventura, Florida, United States

Cooper Green Hospital; 🇺🇸 Birmingham, Alabama, United States

Howard University Hospital; 🇺🇸 Washington, District of Columbia, United States